Exploring 4-(6,7-Dimethoxyquinolin-4-yl)oxyaniline: A Key Intermediate for Cabozantinib Synthesis
Discover the critical role of this high-purity compound in advancing cancer therapies and its importance as a reliable pharmaceutical intermediate.
Get a Quote & SampleProduct Core Value

4-(6,7-Dimethoxyquinolin-4-yl)oxyaniline
This essential compound serves as a pivotal building block in the synthesis of Cabozantinib, a groundbreaking tyrosine kinase inhibitor widely used in cancer treatment. As a leading supplier in China, we provide this intermediate with exceptional purity, ensuring its efficacy in complex pharmaceutical manufacturing processes. Its chemical stability and well-defined structure make it a trusted choice for developing life-saving oncology drugs.
- The synthesis of Cabozantinib relies heavily on this compound, highlighting its significance in the journey to discover new cancer treatments.
- With a purity of ≥98.0% (HPLC), it meets the stringent demands of pharmaceutical production, guaranteeing consistency and quality.
- Leveraging expertise in pharmaceutical intermediate manufacturing, we offer reliable sourcing for your advanced chemical needs.
- Understanding the critical role of each component in developing effective cancer drugs, we ensure the highest standards for this key intermediate.
Key Advantages Offered
High Purity and Consistency
Our commitment to quality ensures that the 4-(6,7-dimethoxyquinolin-4-yl)oxyaniline you receive consistently meets or exceeds the ≥98.0% purity benchmark, vital for successful Cabozantinib synthesis.
Critical Role in Oncology Drug Development
This compound is indispensable for the production of Cabozantinib, a vital tyrosine kinase inhibitor, making it a cornerstone for companies developing advanced cancer therapies.
Reliable Chinese Manufacturing
As a reputable manufacturer in China, we provide scalable and cost-effective access to this essential pharmaceutical intermediate, supporting your production demands.
Key Applications
Cabozantinib Synthesis
This compound is a foundational intermediate for the synthesis of Cabozantinib, a vital drug in the treatment of various cancers. Its precise structure is crucial for the final drug's efficacy.
Tyrosine Kinase Inhibitor Development
Beyond Cabozantinib, it serves as a versatile building block for research and development of other potent tyrosine kinase inhibitors for novel therapeutic applications.
Pharmaceutical Intermediate Manufacturing
Its role as a key intermediate is recognized globally, making it a sought-after chemical for manufacturers focused on producing complex active pharmaceutical ingredients.
Oncology Drug Research
The compound is essential for research into new and improved oncology drugs, contributing to the ongoing fight against cancer through advanced chemical synthesis.